Mark Antonios
About Mark Antonios
Mark Antonios is the Director of Portfolio Congress Strategy, Medical Capabilities at Bristol Myers Squibb, with extensive experience in medical congress strategy and a background in pharmacy.
Company
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for patients with serious diseases. The company focuses on areas such as oncology, immunology, cardiovascular, and fibrosis. Mark Antonios currently serves as the Director of Portfolio Congress Strategy, Medical Capabilities at Bristol Myers Squibb, a role that emphasizes strategic planning and execution for medical congress activities.
Title
Mark Antonios holds the position of Director of Portfolio Congress Strategy, Medical Capabilities at Bristol Myers Squibb. In this capacity, he is responsible for the strategic planning and execution of medical congress activities, with a strong focus on enhancing the company's scientific presence and optimizing the impact of medical congresses on the company’s diverse portfolio.
Education and Expertise
Mark Antonios earned his Doctor of Pharmacy (Pharm.D.) degree from the University of the Sciences in Philadelphia, where he studied from 2006 to 2012. His educational background in pharmacy provides a strong foundation for his roles in medical congress strategy and medical capabilities. His expertise spans strategic planning, medical writing, and portfolio management, which he leverages extensively in his current and past roles at Bristol Myers Squibb.
Professional Background
Mark Antonios has built a robust career in the medical and pharmaceutical fields. He began his journey as a Clinical Pharmacist at The Rasa Group, where he worked from 2012 to 2017. Subsequently, he held multiple roles at Daiichi Sankyo, Inc. and Bristol Myers Squibb. His tenure at Bristol Myers Squibb includes positions such as Medical Writer, Congress Manager, Manager of Congress Strategy Lead, Associate Director of Congress Strategy Lead, and currently as Director of Portfolio Congress Strategy, Medical Capabilities.
Achievements in Medical Congress Strategy
Throughout his career at Bristol Myers Squibb, Mark Antonios has made significant contributions to the company’s presence at major medical congresses. He has led the strategic planning and execution of medical congress activities, elevating the company’s scientific visibility through innovative approaches. His roles have been crucial in the development and implementation of strategies that ensure effective communication and collaboration within the medical community, ultimately optimizing the impact of these congresses on the company’s portfolio.